Pharmacy Benefit Management Market Research Report 2021, Size, Share, Trends and Forecast to 2026
Pharmacy Benefit Management Market Research Report 2021, Size, Share, Trends and Forecast to 2026
Published by IMARC Services Private Limited
Posted on September 9, 2021
According to the latest report by IMARC Group, titled “Pharmacy Benefit Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global pharmacy benefit management market size reached US$ 382.2 Billion in 2020. Pharmacy benefit management (PBM) is a system involving a third-party administrator that manages the prescription of drugs on behalf of pharmacies, health insurers and drug manufacturers. It assists in performing different operations, ranging from financing to setting dispensing policies. It also helps companies to negotiate drug rebates, conduct generic drug substitution with manufacturers and pharmacies, and participate in drug formulary management and development.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Pharmacy Benefit Management Market Trends:
The growing need for cost management services on account of the increasing prevalence of chronic diseases and rising healthcare expenditures represents one of the key factors driving the PBM market. As PBM aids in providing wider access to medications across multiple retail pharmacy networks, its adoption is escalating around the world. Furthermore, the rising integration of specialty pharmacies with PBMs for better connections and expertise with pharmaceutical companies to establish drug contracts is positively influencing the market growth. The increasing number of partnerships and alliances between health insurance companies and PBMs for improving the personalization and affordability of health insurance plans is also strengthening the market growth. Other factors, such as the introduction of advanced benefit management services, including pharmacy-medical integrated products, drug utilization programs and disease management, are anticipated to impel the growth of the market. Looking forward, the market value is projected to reach US$ 538.3 Billion by 2026, expanding at a CAGR of 6.0% during the forecast period (2021-2026).
The report has also analysed the competitive landscape of the market with some of the key players being.
Aetna, Inc.
Centene Corporation
Cigna Corporation
CVS Health Corporation
Express Scripts Holding Company
Magellan Health, Inc.
Medimpact Healthcare Systems, Inc.
Optumrx, Inc.
Prime Therapeutics LLC
ProCare Rx
SS&c Technologies, Inc
Pharmacy Benefit Management Market Segmentation:
Our report has categorized the market based on Region, Service, Business Model and End Use.
Breakup by Service:
Specialty Pharmacy Services
Drug Formulary Management
Retail Pharmacy Services
Benefit Plan Design and Consultation
Disease Management Services
Others
Breakup by Business Model:
Health Insurance Management
Standalone PBMs
Retail Pharmacy
Breakup by End Use:
Federal
Commercial
Breakup by Region:
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
According to the latest report by IMARC Group, titled “Pharmacy Benefit Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global pharmacy benefit management market size reached US$ 382.2 Billion in 2020. Pharmacy benefit management (PBM) is a system involving a third-party administrator that manages the prescription of drugs on behalf of pharmacies, health insurers and drug manufacturers. It assists in performing different operations, ranging from financing to setting dispensing policies. It also helps companies to negotiate drug rebates, conduct generic drug substitution with manufacturers and pharmacies, and participate in drug formulary management and development.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Pharmacy Benefit Management Market Trends:
The growing need for cost management services on account of the increasing prevalence of chronic diseases and rising healthcare expenditures represents one of the key factors driving the PBM market. As PBM aids in providing wider access to medications across multiple retail pharmacy networks, its adoption is escalating around the world. Furthermore, the rising integration of specialty pharmacies with PBMs for better connections and expertise with pharmaceutical companies to establish drug contracts is positively influencing the market growth. The increasing number of partnerships and alliances between health insurance companies and PBMs for improving the personalization and affordability of health insurance plans is also strengthening the market growth. Other factors, such as the introduction of advanced benefit management services, including pharmacy-medical integrated products, drug utilization programs and disease management, are anticipated to impel the growth of the market. Looking forward, the market value is projected to reach US$ 538.3 Billion by 2026, expanding at a CAGR of 6.0% during the forecast period (2021-2026).
The report has also analysed the competitive landscape of the market with some of the key players being.
Aetna, Inc.
Centene Corporation
Cigna Corporation
CVS Health Corporation
Express Scripts Holding Company
Magellan Health, Inc.
Medimpact Healthcare Systems, Inc.
Optumrx, Inc.
Prime Therapeutics LLC
ProCare Rx
SS&c Technologies, Inc
Pharmacy Benefit Management Market Segmentation:
Our report has categorized the market based on Region, Service, Business Model and End Use.
Breakup by Service:
Specialty Pharmacy Services
Drug Formulary Management
Retail Pharmacy Services
Benefit Plan Design and Consultation
Disease Management Services
Others
Breakup by Business Model:
Health Insurance Management
Standalone PBMs
Retail Pharmacy
Breakup by End Use:
Federal
Commercial
Breakup by Region:
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800